Cala Medical is a budding biomedical device company focused on developing therapies for diseases stemming from immune system dysregulation. Founded in 2017 as a spin-out from the University of Limerick, the company is headquartered in Ireland. With the support of angel investors and Enterprise Ireland, Cala Medical aims to bring much-needed new therapy for sepsis patients to the market through its Cytoflow5 technology. The company's mission is underscored by a combination of scientific expertise and business acumen, and its therapies are designed to integrate seamlessly with standard ICU equipment. Cala Medical's recent Venture Round investment in August 2017 further bolsters its pursuit of delivering life-saving therapies, showcasing its potential for impactful growth in the Biotechnology, Health Care, and Life Sciences sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 |
|
03 Aug 2017 |
No recent news or press coverage available for Cala Medical.
We care about your data, and we'd love to use cookies make your experience better.
